Sonoma Pharmaceuticals enters at-the-market sales agreement for up to $2.07 million
PositiveFinancial Markets

Sonoma Pharmaceuticals has announced a new at-the-market sales agreement that could generate up to $2.07 million. This move is significant as it allows the company to raise funds efficiently while potentially expanding its market presence. Investors and stakeholders are likely to view this positively, as it indicates the company's proactive approach to financing and growth in the competitive pharmaceutical landscape.
— Curated by the World Pulse Now AI Editorial System